| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,299 | 16,372 | 16,491 | 17,372 | | Cost of Revenue | 4,632 | 5,232 | 5,962 | 6,434 | | | Gross Profit |
-
| 11,140 | 10,529 | 10,938 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,324 | 10,995 | 9,462 | 9,368 | | Non Recurring |
-
|
-
|
-
| 10,763 | | Others | 3,764 | 4,316 | 4,783 | 18,080 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (4,171) | (3,716) | (27,273) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,421) | (4,171) | (3,716) | (27,273) | | Interest Expense | 309 | 350 | 509 | 637 | | Income Before Tax | (3,730) | (4,521) | (4,225) | (27,910) | | Income Tax Expense |
-
|
-
|
-
| 6,423 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,730) | (4,521) | (4,225) | (34,333) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,730) | (4,521) | (4,225) | (34,333) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,730) | ($4,521) | ($4,225) | ($34,333) |
|
0.47% Nasdaq 
Income Statement
